The warehouse is a lagging indicator — clearances reflect ~12–18 months of prior R&D and regulatory work. This page carries the leading edge: wire-service and registry signals, refreshed with the nightly pipeline, each source going live as its feed comes online.
Warehouse data is a lagging indicator — clearances reflect ~12–18 months of prior R&D and regulatory work. These sources carry the leading edge; each goes live here as its feed comes online.
| Date | Signal | Firm |
|---|---|---|
| 2026-10-08 |
ZEISS acquires Ceres Holographics to accelerate holography industrialization
Combining decades-long holography expertise with complementary holographic innovations JENA, Germany, Oct. 8, 2026 /PRNewswire/ -- ZEISS has announced the acquisition of Ceres Holographics, a pioneering holographic technology company headquartered in Livingston, Scotland. Ceres.. |
— |
| 2026-10-08 |
SIBIONICS y PharmaSens exploran nuevos horizontes en la administración automatizada de insulina en la EASD 2026
MILÁN, 8 de octubre de 2026 /PRNewswire/ -- En la reunión de 2026 de la Asociación Europea para el Estudio de la Diabetes (EASD), SiBionics presentó «See More, Act Earlier» (Ver más, actuar antes), que vincula el monitoreo continuo con el futuro del cuidado de la diabetes. Esta v |
— |
| 2026-10-08 |
Regulated information – inside information: Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range
Regulated information – inside information Nazareth-De Pinte (Belgium)/Rotterdam (The Netherlands), 8 October 2026 – 7:00 AM CET |
— |
| 2026-10-08 |
Gereglementeerde informatie - Voorwetenschap: Fagron realiseert in het derde kwartaal een sterke omzetgroei van 23,2% tot €281,3 miljoen en bevestigt de bandbreedte van haar vooruitzichten voor FY 2026
Gereglementeerde informatie - Voorwetenschap Nazareth-De Pinte (België)/Rotterdam (Nederland), 8 oktober 2026 – 7.00 uur CET |
— |
| 2026-10-07 |
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Mass., Oct. 7, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating |
— |
| 2026-10-07 |
InflammaSense Named Performer on ARPA-H's up to $38 Million CIRCLE Award to Advance Real-Time Immune Monitoring in Critical Care
Company will measure autonomic and inflammatory signatures in up to 200 critically ill patients using its VITALx-patch wearable sensor and ARC cascade-endotyping classifier LA JOLLA, Calif., Oct. 7, 2026 /PRNewswire/ -- InflammaSense, Inc., a pre-revenue medtech company developin |
— |
| 2026-10-07 |
MintNeuro raises $5 million to scale purpose-built chip platform for neural devices and brain-computer interfaces
Funding from European and US investors will accelerate product launch, partner adoption and international expansion LONDON, Oct. 7, 2026 /PRNewswire/ -- MintNeuro, a semiconductor company building specialised chips for neural devices from implants to wearables, today announces a |
— |
| 2026-10-07 |
VSI® Expands Surgical Capabilities to Meet Growing Patient Demand, Welcomes Spine Surgeon Dr. Alexander Upfill-Brown
HSS-trained orthopedic spine surgeon adds surgical capacity and minimally invasive expertise as more patients seek care at the Reston spine center. RESTON, Va., Oct. 7, 2026 /PRNewswire/ -- VSI Spine Solutions (formerly Virginia Spine Institute) announced that orthopedic spine su |
— |
| 2026-10-07 |
SciBase: Recalculation of warrants of series TO 2 following rights issue
STOCKHOLM, Oct. 7, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April 2024, the number of shares that each warrant entitles the holder to subscribe for and the sub |
— |
| 2026-10-07 |
icotec recibe la aprobación de los CMS para el pago adicional por nueva tecnología para su sistema CMORE® CT
NTAP con entrada en vigor el 1 de octubre de 2026, que amplía el acceso a la tecnología de estabilización espinal radiolúcida de icotec para procedimientos de Medicare elegibles. El sistema de implante espinal cervicotorácico (CT) CMORE® es un nuevo componente clave de la crecien |
— |
| 2026-10-07 |
SciBase resolves on a set-off issue of shares to the guarantor in connection with the completed rights issue
STOCKHOLM, Oct. 7, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") has today, on 7 October 2026, resolved on a set-off issue of 60,000 shares to Bergs Securities AB ("Bergs Securities") in its capacity as guarantor in the Company's recently completed r |
— |
| 2026-10-07 |
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC. Roche will preconfigure the instruments and train local laboratory technicians before deploying them to Bunia. INSP will co |
— |
| 2026-10-07 |
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC. Roche will preconfigure the instruments and train local laboratory technicians before deploying them to Bunia. INSP will co |
— |
| 2026-10-07 |
Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder
ALISO VIEJO, Calif., Oct. 7, 2026 /PRNewswire/ -- Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S. FDA has granted an expanded indication for its LOBO® Vascular Occlusion System. The expanded indication ex |
— |
| 2026-10-07 |
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc. (MiniMed; Nasdaq: MME |
— |
| 2026-10-07 |
Medicus Healthcare Solutions Releases 2026 Report on Rising Demand in Emergency Medicine
WINDHAM, N.H., Oct. 7, 2026 /PRNewswire/ -- Emergency department (ED) volumes are projected to grow 6% over the next decade, adding to the pressures already shaping emergency care delivery across the United States. To help healthcare leaders better understand the factors driving |
— |
| 2026-10-07 |
Resonant Clinical Solutions und Haier Biomedical stellen eine innovative Tischzentrifuge mit einem natürlichen Kältemittel vor
Aus einer exklusiven Partnerschaft entsteht eine nutzerorientierte, mit Kohlenwasserstoffen gekühlte Zentrifuge, die speziell für klinische Studien entwickelt wurde – und damit den bevorstehenden Änderungen der F-Gas-Vorschriften in Europa und den USA um Jahre voraus ist. LEESBUR |
— |
| 2026-10-07 |
Boehringer Ingelheim's New Quarterable Snap-Tab PREVICOX® (firocoxib) Chewable Tablets Provide Flexible Dosing for Dogs in the U.S.
Now approved by the U.S. Food and Drug Administration, this unique tablet design enables more precise, customizable dosing based on dog's weight, as well as improved convenience and cost-effectiveness. The new design for PREVICOX® tablets and packaging offers sustainability benefi |
— |
| 2026-10-07 |
Cold Plasma in Healthcare Market to Reach USD 6,634 Million by 2032 - Credence Research
LONDON, Oct. 7, 2026 /PRNewswire/ -- The "Cold Plasma in Healthcare Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2032" report has been added to the Credence Research Inc. offering. The global Cold Plasma in Healthcare Market was valued at USD 2,873 million i |
— |
| 2026-10-07 |
Resonant Clinical Solutions et Haier Biomedical lancent une centrifugeuse de paillasse innovante fonctionnant avec un réfrigérant naturel
Ce partenariat exclusif a donné naissance à une centrifugeuse à refroidissement par hydrocarbures, conçue spécialement pour les essais cliniques et axée sur les besoins des utilisateurs, qui devance de plusieurs années les prochaines évolutions réglementaires relatives aux gaz fl |
— |
| 2026-10-07 |
Tennessee Oncology Physician Contributes to Landmark Longevity Research
Dr. Yanjun Ma helps uncover genetic and epigenetic clues to extraordinary longevity and cancer resistance in 194-year-old giant tortoise NASHVILLE, Tenn., Oct. 7, 2026 /PRNewswire/ -- Tennessee Oncology is contributing to groundbreaking research into one of biology's most endurin |
— |
| 2026-10-07 |
InventHelp Inventors Develop New Doggie Cone Edge Protector (RKH-1279)
PITTSBURGH, Oct. 7, 2026 /PRNewswire/ -- "I thought there should be a way to protect people against the hard plastic edge on my dog's cone collar," said an inventor, from Woodbridge, Va., "so we invented the DOGGIE CONE EDGE PROTECTOR. Our soft and protective design helps prevent |
— |
| 2026-10-07 |
MAXAIR SYSTEMS CONTINUES SUPPORT OF WORLD VISION'S EBOLA RESPONSE EFFORTS IN THE DEMOCRATIC REPUBLIC OF THE CONGO
Longtime supporter plans to provide respiratory protection systems to help protect frontline personnel IRVINE, Calif., Oct. 7, 2026 /PRNewswire/ -- MAXAIR Systems, a leading provider of advanced respiratory protection, today announced plans to continue its longstanding support of |
— |
| 2026-10-07 |
ClearSky Health to Build New Medical Rehabilitation Hospital in North Carolina
ALBUQUERQUE, N.M., Oct. 7, 2026 /PRNewswire/ -- ClearSky Health, a premier rehabilitative healthcare provider, has announced plans to build a new 36-bed medical rehabilitation hospital in Smithfield, N.C., which is expected to treat more than 650 patients annually and create abou |
— |
| 2026-10-07 |
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
BAD HOMBURG, Germany, Oct. 7, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy (51) will become Chief Executive Officer (CEO) and Chair of the Mana |
— |
| 2026-10-07 |
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)
PITTSBURGH, Oct. 7, 2026 /PRNewswire/ -- "I wanted to create a cap accessory to provide hot and cold therapy for the head and neck," said an inventor, from Oak Harbor, Wash., "so I invented the NEURO CAP. The versatility and targeted comfort of my design make it ideal for managin |
— |
| 2026-10-07 |
Hyundai and UCI Health Continue Collaboration to Advance Child Passenger Safety in Southern California
Hyundai donates $25,000 to support UCI Health's Federally Qualified Health Center Car Seat Safety Program Community event provides free inspections, education, and safety resources for local families ANAHEIM, Calif., Oct. 7, 2026 /PRNewswire/ -- Hyundai Motor America and UCI Heal |
— |
| 2026-10-07 |
Aufstrebende Biotech-Unternehmen setzen einheitlich auf Veeva Basics, um die Arzneimittelentwicklung zu beschleunigen
Mehr als 175 Biotech-Unternehmen nutzen vorkonfigurierte Anwendungen, um ihre Abläufe zu optimieren PLEASANTON, Kalifornien, 7. Oktober 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass mehr als 175 aufstrebende Biotech-Unternehmen mit Veeva Basics eine... |
— |
| 2026-10-07 |
Dignify Therapeutics Advances into Clinic with FDA Clearance of IND for DTI-117 in Neurogenic Bowel Dysfunction
NIH-funded randomized, double-blind, placebo-controlled Phase 1 single-ascending-dose study expected to begin dosing healthy volunteers in November 2026 Preliminary topline data from initial cohorts anticipated in early 2027 RESEARCH TRIANGLE PARK, N.C., Oct. 7, 2026 /PRNewswire/ |
— |
| 2026-10-07 |
Sonorous Neurovascular Receives FDA IDE Approval for First U.S. Pivotal Trial of a Venous Sinus Stent to Treat Pulsatile Tinnitus
B-SILENT 2 adds a U.S. pivotal study to the company's international clinical program and advances its cerebral venous disease platform LAKE FOREST, Calif., Oct. 7, 2026 /PRNewswire/ -- Sonorous Neurovascular, a clinical-stage medical device company developing purpose-built therap |
— |
New trial starts and registry updates — a strong leading indicator for where R&D money is being spent.
MD&M, RSNA, AAOS, AAOMS, ADA, ASCO, HIMSS, CES Health. Next-30-days view of firms exhibiting and what they're launching — real-time signal of where the booth budget is going.
MedTech Dive, MassDevice, MedCity News, MD+DI editorial + SEC 8-K M&A filings. Concurrent and retrospective context.
| Date | Signal | Firm |
|---|---|---|
| 2026-07-26 |
AI device authorizations: what the FDA record shows
FDA authorizations for AI-enabled imaging software grew twentyfold from 2018 to 2025 — then flattened in 2026. Every count queried from openFDA, query… |
— |
| 2026-07-26 |
What a 510(k) clearance does not guarantee a buyer
A 510(k) clearance makes an AI device legal to sell — not clinically superior or commercially proven. The four gaps category buyers have to close themselves. |
— |
| 2026-07-26 |
FDA cleared vs approved vs granted vs registered
Cleared, approved, granted, and registered mean very different things at the FDA. What each proves about an AI tool, and how to verify any claim yourself. |
— |
| 2026-07-25 |
Introducing Insights
Welcome to Insights, the new analysis section of Elephant Hawk. Each week we publish a short, data-driven read on the medtech regulatory landscape — built… |
— |